Last updated on March 2019

Open Label Safety Study in Acute Treatment of Migraine

Brief description of study

The purpose of this study is to evaluate safety and tolerability of BHV3000 (rimegepant).

Clinical Study Identifier: NCT03266588

Contact Investigators or Research Sites near you

Start Over

Radiant Research, Inc.

Anderson, SC United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.